PolyPid Ltd.
PolyPid Ltd.
Your view on PYPD
Overview
What the company does, where it operates, and who runs it.
About PolyPid Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Dikla Czaczkes Akselbrad
- Headquarters
- 18 Hasivim Street, Petah Tikva, IL
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Dikla Czaczkes Akselbrad
- Headquarters
- 18 Hasivim Street, Petah Tikva, IL
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.